Ovarian Cancer section

Ovarian Cancer News & Features

FDA approves Avastin for platinum-resistant, recurrent ovarian cancer

FDA approves Avastin for platinum-resistant, recurrent ovarian cancer

FDA has approved Avastin (bevacizumab) for treatment of platinum-resistant recurrent epithelial ovarian cancer.

Mexican women with family history more likely to have triple-negative breast cancer vs. other types

Mexican women with family history more likely to have triple-negative breast cancer vs. other types

Patients of Mexican descent with breast cancer and family history of breast or ovarian cancer were nearly two times as likely to have triple negative breast cancer.

People with lactose intolerance may have decreased risk of breast, lung, and ovarian cancers

People with lactose intolerance may have decreased risk of breast, lung, and ovarian cancers

People who are lactose intolerant have a decreased risk for developing breast, lung, and ovarian cancers.

Use of hospital-based services, as well as hospice, increased among patients with ovarian cancer

Patients with ovarian cancer, despite an increasing use of hospital services, are more likely to enter hospice and less likely to die in the hospital, investigators found.

For patients with recurrent ovarian cancer, trebananib did not improve overall survival

For patients with recurrent ovarian cancer, trebananib did not improve overall survival

Results from TRINOVA-1 study that investigated trebananib plus paclitaxel for the treatment of patients with ovarian cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs